Circulating tumor cells: what goes around, comes around

Affiliations

¹ Affiliations of authors: Department of Pathology (AMS, NN) and Department of Surgery (AMS), The George Washington University, Washington, DC. aschwartz@mfa.gwu.edu.
² Affiliations of authors: Department of Pathology (AMS, NN) and Department of Surgery (AMS), The George Washington University, Washington, DC.

Editorial

Arnold M Schwartz et al. J Natl Cancer Inst. 2014.

. 2014 May 15;106(5):dju108.

doi: 10.1093/jnci/dju108.

¹ Affiliations of authors: Department of Pathology (AMS, NN) and Department of Surgery (AMS), The George Washington University, Washington, DC. aschwartz@mfa.gwu.edu.
² Affiliations of authors: Department of Pathology (AMS, NN) and Department of Surgery (AMS), The George Washington University, Washington, DC.

No abstract available

Comment on

Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.
Rack B, Schindlbeck C, Jückstock J, Andergassen U, Hepp P, Zwingers T, Friedl TW, Lorenz R, Tesch H, Fasching PA, Fehm T, Schneeweiss A, Lichtenegger W, Beckmann MW, Friese K, Pantel K, Janni W; SUCCESS Study Group. Rack B, et al. J Natl Cancer Inst. 2014 May 15;106(5):dju066. doi: 10.1093/jnci/dju066. J Natl Cancer Inst. 2014. PMID: 24832787 Free PMC article. Clinical Trial.